Form 13-F position report

BOLT BIOTHERAPEUTICS, INC COM

Reported by SBI Securities Co Ltd

BOLT CUSIP 097702104 Manager CIK 0001851815

Reported 0 shares, down 200 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2025
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2024-12-31 107
2025-03-31 80
2025-06-30 0
2025-06-30 58
2025-09-30 53
2025-12-31 55
2026-03-31 40
2026-06-30 501
2026-09-30 37

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for BOLT BIOTHERAPEUTICS, INC COM held by SBI Securities Co Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 10 -120 (-92.3%) < 0.01% $37 2026-10-22
Q2 2026 Added 130 +120 (1200.0%) < 0.01% $501 2026-07-23
Q1 2026 Unchanged 10 0 (0.0%) < 0.01% $40 2026-04-28
Q4 2025 Unchanged 10 0 (0.0%) < 0.01% $55 2026-02-03
Q3 2025 Unchanged 10 0 (0.0%) < 0.01% $53 2025-11-05
Q2 2025 New 10 +10 (0.0%) < 0.01% $58 2025-08-08
Q2 2025 Reduced 0 -200 (-100.0%) 0 $0 2025-08-08
Q1 2025 Unchanged 200 0 (0.0%) < 0.01% $80 2025-05-02
Q4 2024 New 200 +200 (0.0%) < 0.01% $107 2025-02-06

Who else reported the position

31 managers reported BOLT BIOTHERAPEUTICS, INC COM for Q2 2025.

Managers reporting BOLT BIOTHERAPEUTICS, INC COM in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 0 -268,640 0 $0 4 qtrs
SALEM INVESTMENT COUNSELORS INC Reduced 0 -40 0 $0 14 qtrs
Sofinnova Investments Inc Reduced 0 -2,754,437 0 $0 18 qtrs
VANGUARD GROUP INC Reduced 0 -1,169,705 0 $0 18 qtrs
NORTHERN TRUST CORPORATION Reduced 0 -40,895 0 $0 18 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 0 -21,733 0 $0 5 qtrs
Board of Trustees of The Leland Stanford Junior University Reduced 0 -719,546 0 $0 17 qtrs
Mariner LLC Reduced 0 -40,000 0 $0 4 qtrs
StoneX Group Inc Reduced 0 -15,532 0 $0 2 qtrs
Vivo Capital LLC Reduced 0 -3,521,291 0 $0 18 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 08, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.